Kuano Featured in GeneOnline: Quantum Drug Discovery in Action
We’re proud to share that Kuano has been featured in GeneOnline’s latest article on the growing impact of quantum computing in life sciences. The piece explores how quantum approaches are advancing drug discovery — and highlights Kuano as a leading innovator in the field.
📖 Read the full article here:
👉 Unlocking the Potential of Quantum Computing (GeneOnline)
At Kuano, we’ve built a next-gen platform that merges quantum simulations, AI, and enzyme structural insights to design more potent, selective, and resistance-proof drugs. It’s not just theoretical — our patented technology is already delivering high-value molecules.
Why Kuano?
🔬 Quantum-native expertise – built on deep scientific foundations
🔒 Patented precision – delivering a new level of accuracy in drug discovery
⚙️ Fully operational platform – in-house programs are already in motion
And we’re going beyond enzymes, too — with quantum-enhanced tools like covalent inhibitor reactivity prediction expanding what’s possible in small molecule design.
Where We're Focused
We’re advancing internal drug discovery programs in:
Oncology & immuno-oncology
Epigenetics & neurodegeneration
Challenging target classes, including Phosphatases
…and working with partners to co-develop the next generation of enzyme inhibitors for proven targets.
💡 Curious to learn more?
Let’s talk. Reach us at contact@kuano.ai
The future of medicine is quantum-powered — and Kuano is making it real.
